$KFRC
KFORCE INC Stock $kfrc

$kfrc Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000093042024000080 Filed on May 01, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$356.3M	$351.9M
YoY Change	-8.45%	-13.33%
Cost Of Revenue	$257.3M	$256.6M
YoY Change	-7.74%	-12.12%
Gross Profit	$98.97M	$95.25M
YoY Change	-10.24%	-16.43%
Gross Profit Margin	27.78%	27.07%
Selling, General & Admin	$77.72M	$78.19M
YoY Change	-6.36%	-12.48%
% of Gross Profit	78.52%	82.09%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.555M	$1.333M
YoY Change	16.04%	8.02%
% of Gross Profit	1.57%	1.4%
Operating Expenses	$79.78M	$80.18M
YoY Change	-5.4%	-12.49%
Operating Profit	$19.70M	$15.73M
YoY Change	-24.04%	-32.8%
Interest Expense	-$504.0K	-$655.0K
YoY Change	61.02%	121.28%
% of Operating Profit	-2.56%	-4.16%
Other Income/Expense, Net	-$504.0K	-$656.0K
YoY Change	61.02%	-37.22%
Pretax Income	$19.20M	$15.07M
YoY Change	-25.07%	-32.59%
Income Tax	$5.039M	$4.084M
% Of Pretax Income	26.25%	27.1%
Net Earnings	$14.16M	$10.99M
YoY Change	-23.78%	-32.22%
Net Earnings / Revenue	3.97%	3.12%
Basic Earnings Per Share	$0.76	$0.59
Diluted Earnings Per Share	$0.75	$0.58
COMMON SHARES
Basic Shares Outstanding	19.49M shares	19.52M shares
Diluted Shares Outstanding	18.89M shares	18.93M shares

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$110.0K	$106.0K
YoY Change	-25.17%	-38.01%
Cash & Equivalents	$110.0K	$106.0K
Short-Term Investments
Other Short-Term Assets	$8.310M	$9.146M
YoY Change	-4.95%	11.36%
Inventory
Prepaid Expenses
Receivables	$230.7M	$236.9M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$239.1M	$246.2M
YoY Change	-7.83%	-10.45%
LONG-TERM ASSETS
Property, Plant & Equipment	$8.526M	$8.936M
YoY Change	-63.18%	-10.96%
Goodwill	$25.04M	$25.04M
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments	$45.80M	$44.03M
YoY Change	24.93%	28.27%
Other Assets	$85.39M	$82.80M
YoY Change	923.94%	15.51%
Total Long-Term Assets	$123.6M	$120.2M
YoY Change	13.75%	8.99%
TOTAL ASSETS
Total Short-Term Assets	$239.1M	$246.2M
Total Long-Term Assets	$123.6M	$120.2M
Total Assets	$362.7M	$366.3M
YoY Change	-1.46%	-4.89%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$42.39M	$43.20M
YoY Change	-8.43%	-9.93%
Accrued Expenses	$5.047M	$5.691M
YoY Change	-91.14%	-73.71%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$102.8M	$106.1M
YoY Change	-1.35%	-15.63%
LONG-TERM LIABILITIES
Long-Term Debt	$36.70M	$40.80M
YoY Change	49.19%	82.96%
Other Long-Term Liabilities	$56.53M	$54.92M
YoY Change	9.54%	6.92%
Total Long-Term Liabilities	$56.53M	$54.92M
YoY Change	-25.82%	6.92%
TOTAL LIABILITIES
Total Short-Term Liabilities	$102.8M	$106.1M
Total Long-Term Liabilities	$56.53M	$54.92M
Total Liabilities	$196.1M	$201.8M
YoY Change	8.65%	1.2%
SHAREHOLDERS EQUITY
Retained Earnings	$535.6M	$528.8M
YoY Change	4.41%	5.42%
Common Stock	$735.0K	$735.0K
YoY Change	0.41%	0.41%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$166.6M	$164.5M
YoY Change
Total Liabilities & Shareholders Equity	$362.7M	$366.3M
YoY Change	-1.46%	-4.89%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	$14.16M	$10.99M
YoY Change	-23.78%	-32.22%
Depreciation, Depletion And Amortization	$1.555M	$1.333M
YoY Change	16.04%	8.02%
Cash From Operating Activities	$20.94M	$13.17M
YoY Change	-2.05%	-30.89%
INVESTING ACTIVITIES
Capital Expenditures	$3.104M	$1.875M
YoY Change	0.84%	0.16%
Acquisitions
YoY Change
Other Investing Activities	$1.756M	-$529.0K
YoY Change	-1009.84%	-112.28%
Cash From Investing Activities	-$1.348M	-$2.404M
YoY Change	-58.79%	-198.65%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-19.58M	-$10.78M
YoY Change	8.03%	-49.74%
NET CHANGE
Cash From Operating Activities	20.94M	$13.17M
Cash From Investing Activities	-1.348M	-$2.404M
Cash From Financing Activities	-19.58M	-$10.78M
Net Change In Cash	4.000K	-$13.00K
YoY Change	-116.67%	-126.0%
FREE CASH FLOW
Cash From Operating Activities	$20.94M	$13.17M
Capital Expenditures	$3.104M	$1.875M
Free Cash Flow	$17.83M	$11.29M
YoY Change	-2.54%	-34.28%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	164505000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	256639000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	292021000	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	95250000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	113976000	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	78190000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	89339000	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1333000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1234000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	15727000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	23403000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-656000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1045000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	15071000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	22358000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4084000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6148000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	10987000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	16210000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.59
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.83
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.58
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.82
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18726000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19455000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18932000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19667000	shares
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	106000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	119000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1670000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1643000	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	236923000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	233428000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9146000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	10912000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	246175000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	244459000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8936000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9418000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	82800000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	75924000	usd
CY2024Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	3382000	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	3138000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	25040000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	25040000	usd
CY2024Q1	us-gaap	Assets Assets	366333000	usd
CY2023Q4	us-gaap	Assets Assets	357979000	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	59415000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	64795000	usd
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	39746000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	33968000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3423000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3589000	usd
CY2024Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	3520000	usd
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	623000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	106104000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	102975000	usd
CY2024Q1	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	40800000	usd
CY2023Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	41600000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	54924000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	54324000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	201828000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	198899000	usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	15000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	15000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	73455000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	73462000	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	735000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	734000	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	531226000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	527288000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	528795000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	525222000	usd
CY2024Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	53968000	shares
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	53941000	shares
CY2024Q1	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	896251000	usd
CY2023Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	894164000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	164505000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	159080000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	366333000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	357979000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	159080000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	10987000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	0	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3501000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	204000	usd
CY2024Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.38
CY2024Q1	us-gaap	Dividends Common Stock DividendsCommonStock	7128000	usd
CY2024Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	2139000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	182198000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	16210000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-1000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4326000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	245000	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.36
CY2023Q1	us-gaap	Dividends Common Stock DividendsCommonStock	7003000	usd
CY2023Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	10244000	usd
CY2023Q1	us-gaap	Stockholders Equity Other StockholdersEquityOther	6000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	185725000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	10987000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	16210000	usd
CY2024Q1	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-244000	usd
CY2023Q1	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	1301000	usd
CY2024Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	-40000	usd
CY2023Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	371000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1333000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1234000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	3501000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	4326000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	938000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1130000	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-750000	usd
CY2024Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-404000	usd
CY2023Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-50000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3456000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2601000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	608000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-243000	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	5982000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-1230000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-5628000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-7930000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	13169000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	19056000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1875000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1872000	usd
CY2024Q1	us-gaap	Payments To Acquire Life Insurance Policies PaymentsToAcquireLifeInsurancePolicies	529000	usd
CY2023Q1	us-gaap	Payments To Acquire Life Insurance Policies PaymentsToAcquireLifeInsurancePolicies	0	usd
CY2024Q1	us-gaap	Proceeds From Divestiture Of Interest In Joint Venture ProceedsFromDivestitureOfInterestInJointVenture	0	usd
CY2023Q1	us-gaap	Proceeds From Divestiture Of Interest In Joint Venture ProceedsFromDivestitureOfInterestInJointVenture	5059000	usd
CY2024Q1	kfrc	Receivable Issued To Joint Venture ReceivableIssuedToJointVenture	0	usd
CY2023Q1	kfrc	Receivable Issued To Joint Venture ReceivableIssuedToJointVenture	750000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2404000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	2437000	usd
CY2024Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	107600000	usd
CY2023Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	174200000	usd
CY2024Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	108400000	usd
CY2023Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	177500000	usd
CY2024Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2848000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	11126000	usd
CY2024Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	7128000	usd
CY2023Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	7003000	usd
CY2024Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-2000	usd
CY2023Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-14000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-10778000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-21443000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-13000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	50000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	119000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	121000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	106000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	171000	usd
CY2024Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	300000	usd
CY2023Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	5108000	usd
CY2024Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	1297000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	1303000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	614000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	248000	usd
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1152000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	566000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	204000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	245000	usd
CY2024Q1	kfrc	Stock Repurchases Incurred But Not Yet Paid StockRepurchasesIncurredButNotYetPaid	200000	usd
CY2023Q1	kfrc	Stock Repurchases Incurred But Not Yet Paid StockRepurchasesIncurredButNotYetPaid	0	usd
CY2024Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	181000	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	957000	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:5pt"><span style="color:#004b8d;font-family:'Open Sans Light',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Open Sans Light',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The most critical of these estimates and assumptions relate to the following: allowance for credit losses; income taxes; self-insured liabilities for health insurance; and the impairment of goodwill. Although these and other estimates and assumptions are based on the best available information, actual results could be materially different from these estimates. Therefore, our accounting estimates and assumptions might change materially in future periods.</span></div>
CY2024Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	206000	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	212000	shares
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1000	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	264000	shares
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	351889000	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	95250000	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	80179000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	15071000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	405997000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	113976000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	91618000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	22358000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	351889000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	405997000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1106000	usd
CY2024Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-40000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	61000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1005000	usd
CY2024Q1	kfrc	Accounts Receivable Allowance For Credit Loss Allowance Unrelated To Trade Receivables AccountsReceivableAllowanceForCreditLossAllowanceUnrelatedToTradeReceivables	700000	usd
CY2023Q4	kfrc	Accounts Receivable Allowance For Credit Loss Allowance Unrelated To Trade Receivables AccountsReceivableAllowanceForCreditLossAllowanceUnrelatedToTradeReceivables	500000	usd
CY2024Q1	us-gaap	Deferred Compensation Plan Assets DeferredCompensationPlanAssets	44025000	usd
CY2023Q4	us-gaap	Deferred Compensation Plan Assets DeferredCompensationPlanAssets	40389000	usd
CY2024Q1	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	20620000	usd
CY2023Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	16434000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	14504000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	14368000	usd
CY2024Q1	us-gaap	Debt Issuance Costs Line Of Credit Arrangements Net DebtIssuanceCostsLineOfCreditArrangementsNet	598000	usd
CY2023Q4	us-gaap	Debt Issuance Costs Line Of Credit Arrangements Net DebtIssuanceCostsLineOfCreditArrangementsNet	658000	usd
CY2024Q1	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	3053000	usd
CY2023Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	4075000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	82800000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	75924000	usd
CY2024Q1	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	39600000	usd
CY2023Q4	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	37600000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	43202000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	42842000	usd
CY2024Q1	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	6746000	usd
CY2023Q4	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	5927000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5691000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8699000	usd
CY2024Q1	kfrc	Accrued Rebate Liability Current AccruedRebateLiabilityCurrent	3776000	usd
CY2023Q4	kfrc	Accrued Rebate Liability Current AccruedRebateLiabilityCurrent	7327000	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	59415000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	64795000	usd
CY2024Q1	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	31075000	usd
CY2023Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	28110000	usd
CY2024Q1	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	4329000	usd
CY2023Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	1705000	usd
CY2024Q1	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	3809000	usd
CY2023Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	3727000	usd
CY2024Q1	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	533000	usd
CY2023Q4	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	426000	usd
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	39746000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	33968000	usd
CY2024Q1	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	42519000	usd
CY2023Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	42025000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	12383000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	12275000	usd
CY2024Q1	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	22000	usd
CY2023Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	24000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	54924000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	54324000	usd
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3500000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4300000	usd
CY2024Q1	kfrc	Supplemental Unemployment Benefits On Change In Control SupplementalUnemploymentBenefitsOnChangeInControl	30400000	usd
CY2024Q1	kfrc	Supplemental Unemployment Benefits On No Change In Control SupplementalUnemploymentBenefitsOnNoChangeInControl	11500000	usd
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0000930420-24-000080-index-headers.html	Edgar Link	pending
0000930420-24-000080-index.html	Edgar Link	pending
0000930420-24-000080.txt	Edgar Link	pending
0000930420-24-000080-xbrl.zip	Edgar Link	pending
exhibit311q12024.htm	Edgar Link	pending
exhibit312q12024.htm	Edgar Link	pending
exhibit321q12024.htm	Edgar Link	pending
exhibit322q12024.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
kfrc-20240331.htm	Edgar Link	pending
kfrc-20240331.xsd	Edgar Link	pending
kfrc-20240331_g1.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
kfrc-20240331_cal.xml	Edgar Link	unprocessable
kfrc-20240331_lab.xml	Edgar Link	unprocessable
kfrc-20240331_pre.xml	Edgar Link	unprocessable
kfrc-20240331_htm.xml	Edgar Link	completed
kfrc-20240331_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KFRC
KFORCE INC Stock $kfrc

2024 Q2 Form 10-Q Financial Statement

#000093042024000080 Filed on May 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KFRC KFORCE INC Stock $kfrc

2024 Q2 Form 10-Q Financial Statement

#000093042024000080 Filed on May 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KFRC
KFORCE INC Stock $kfrc